A citation-based method for searching scientific literature

Ulf M Geisen, Dennis K Berner, Florian Tran, Melike Sümbül, Lena Vullriede, Maria Ciripoi, Hayley M Reid, Annika Schaffarzyk, Ann C Longardt, Jeanette Franzenburg, Paula Hoff, Jan H Schirmer, Rainald Zeuner, Anette Friedrichs, Andrea Steinbach, Christine Knies, Robert Dh Markewitz, Peter J Morrison, Sascha Gerdes, Stefan Schreiber, Bimba F Hoyer. Ann Rheum Dis 2021
Times Cited: 202







List of co-cited articles
574 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Victoria Furer, Tali Eviatar, Devy Zisman, Hagit Peleg, Daphna Paran, David Levartovsky, Michael Zisapel, Ofir Elalouf, Ilana Kaufman, Roni Meidan,[...]. Ann Rheum Dis 2021
239
57

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
45

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.
David Simon, Koray Tascilar, Filippo Fagni, Gerhard Krönke, Arnd Kleyer, Christine Meder, Raja Atreya, Moritz Leppkes, Andreas E Kremer, Andreas Ramming,[...]. Ann Rheum Dis 2021
105
36

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease.
Rebecca H Haberman, Ramin Herati, David Simon, Marie Samanovic, Rebecca B Blank, Michael Tuen, Sergei B Koralov, Raja Atreya, Koray Tascilar, Joseph R Allen,[...]. Ann Rheum Dis 2021
122
34

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
34

Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2.
Yolanda Braun-Moscovici, Marielle Kaplan, Maya Braun, Doron Markovits, Samy Giryes, Kohava Toledano, Yonit Tavor, Katya Dolnikov, Alexandra Balbir-Gurman. Ann Rheum Dis 2021
92
30

Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.
Parakkal Deepak, Wooseob Kim, Michael A Paley, Monica Yang, Alexander B Carvidi, Emanuel G Demissie, Alia A El-Qunni, Alem Haile, Katherine Huang, Baylee Kinnett,[...]. Ann Intern Med 2021
132
23

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
Brian J Boyarsky, Jake A Ruddy, Caoilfhionn M Connolly, Michael T Ou, William A Werbel, Jacqueline M Garonzik-Wang, Dorry L Segev, Julie J Paik. Ann Rheum Dis 2021
112
22

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
David S Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E Schlub, Adam K Wheatley, Jennifer A Juno, Kanta Subbarao, Stephen J Kent, James A Triccas, Miles P Davenport. Nat Med 2021
21

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.
Ana C Medeiros-Ribeiro, Nadia E Aikawa, Carla G S Saad, Emily F N Yuki, Tatiana Pedrosa, Solange R G Fusco, Priscila T Rojo, Rosa M R Pereira, Samuel K Shinjo, Danieli C O Andrade,[...]. Nat Med 2021
71
29


SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
Daniel Mrak, Selma Tobudic, Maximilian Koblischke, Marianne Graninger, Helga Radner, Daniela Sieghart, Philipp Hofer, Thomas Perkmann, Helmuth Haslacher, Renate Thalhammer,[...]. Ann Rheum Dis 2021
117
17

The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.
Satveer K Mahil, Katie Bechman, Antony Raharja, Clara Domingo-Vila, David Baudry, Matthew A Brown, Andrew P Cope, Tejus Dasandi, Carl Graham, Thomas Lechmere,[...]. Lancet Rheumatol 2021
75
22

High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.
Jake A Ruddy, Caoilfhionn Marie Connolly, Brian J Boyarsky, William A Werbel, Lisa Christopher-Stine, Jacqueline Garonzik-Wang, Dorry L Segev, Julie J Paik. Ann Rheum Dis 2021
76
21

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, Brian Angus, Vicky L Baillie, Shaun L Barnabas, Qasim E Bhorat,[...]. Lancet 2021
16

Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Christian Ammitzbøll, Lars Erik Bartels, Jakob Bøgh Andersen, Signe Risbøl Vils, Clara Elbaek Mistegård, Anders Dahl Johannsen, Marie-Louise From Hermansen, Marianne Kragh Thomsen, Christian Erikstrup, Ellen-Margrethe Hauge,[...]. ACR Open Rheumatol 2021
42
35

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, Reuben J Arasaratnam, Lindsey R Baden, Anne R Bass, Cassandra Calabrese, Ellen M Gravallese, Rafael Harpaz, Andrew Kroger,[...]. Arthritis Rheumatol 2021
78
19

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.
Laura Boekel, Maurice Steenhuis, Femke Hooijberg, Yaëlle R Besten, Zoé L E van Kempen, Laura Y Kummer, Koos P J van Dam, Eileen W Stalman, Erik H Vogelzang, Olvi Cristianawati,[...]. Lancet Rheumatol 2021
73
20

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
Sebastian Eduardo Sattui, Jean W Liew, Kevin Kennedy, Emily Sirotich, Michael Putman, Tarin T Moni, Akpabio Akpabio, Deshiré Alpízar-Rodríguez, Francis Berenbaum, Inita Bulina,[...]. RMD Open 2021
51
29

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Anja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, Saskia Lawson-Tovey, Jean W Liew, Lotta Ljung, Elsa F Mateus, Christophe Richez, Maria J Santos, Gabriela Schmajuk,[...]. Ann Rheum Dis 2021
283
14

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, Reuben J Arasaratnam, Lindsey R Baden, Anne R Bass, Cassandra Calabrese, Ellen M Gravallese, Rafael Harpaz, Andrew Kroger,[...]. Arthritis Rheumatol 2021
50
28

Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey.
Somy Cherian, Aby Paul, Sakir Ahmed, Bazil Alias, Manesh Manoj, Ansu K Santhosh, Delcey Rachel Varghese, Narayanan Krishnan, Padmanabha Shenoy. Rheumatol Int 2021
33
42

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis.
Andrea Rubbert-Roth, Nicolas Vuilleumier, Burkhard Ludewig, Kristin Schmiedeberg, Christoph Haller, Johannes von Kempis. Lancet Rheumatol 2021
33
42

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression.
Maria Prendecki, Candice Clarke, Helena Edwards, Stacey McIntyre, Paige Mortimer, Sarah Gleeson, Paul Martin, Tina Thomson, Paul Randell, Anand Shah,[...]. Ann Rheum Dis 2021
103
14

Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2.
Parakkal Deepak, Wooseob Kim, Michael A Paley, Monica Yang, Alexander B Carvidi, Alia A El-Qunni, Alem Haile, Katherine Huang, Baylee Kinnett, Mariel J Liebeskind,[...]. medRxiv 2021
69
18

Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Peter M Izmirly, Mimi Y Kim, Marie Samanovic, Ruth Fernandez-Ruiz, Sharon Ohana, Kristina K Deonaraine, Alexis J Engel, Mala Masson, Xianhong Xie, Amber R Cornelius,[...]. Arthritis Rheumatol 2022
40
32


Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
Brian J Boyarsky, William A Werbel, Robin K Avery, Aaron A R Tobian, Allan B Massie, Dorry L Segev, Jacqueline M Garonzik-Wang. JAMA 2021
339
12

Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly.
Emire Seyahi, Guldaran Bakhdiyarli, Mert Oztas, Mert Ahmet Kuskucu, Yesim Tok, Necdet Sut, Guzin Ozcifci, Ali Ozcaglayan, Ilker Inanc Balkan, Nese Saltoglu,[...]. Rheumatol Int 2021
38
31

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
Nicholas A Kennedy, Simeng Lin, James R Goodhand, Neil Chanchlani, Benjamin Hamilton, Claire Bewshea, Rachel Nice, Desmond Chee, Jr Fraser Cummings, Aileen Fraser,[...]. Gut 2021
132
12

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. N Engl J Med 2020
12

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Victoria Furer, Christien Rondaan, Marloes W Heijstek, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Ferry C Breedveld, Raffaele D'Amelio, Maxime Dougados, Meliha Crnkic Kapetanovic,[...]. Ann Rheum Dis 2020
278
12

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn, Paul A Goepfert, Carla Truyers, Hein Fennema, Bart Spiessens,[...]. N Engl J Med 2021
11

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
Brian J Boyarsky, William A Werbel, Robin K Avery, Aaron A R Tobian, Allan B Massie, Dorry L Segev, Jacqueline M Garonzik-Wang. JAMA 2021
512
11

Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis.
Anuraag Jena, Shubhra Mishra, Parakkal Deepak, Praveen Kumar-M, Aman Sharma, Yusuf I Patel, Nicholas A Kennedy, Alfred H J Kim, Vishal Sharma, Shaji Sebastian. Autoimmun Rev 2022
49
22

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, Loreto Carmona, Maria I Danila, Laure Gossec, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Saskia Lawson-Tovey,[...]. Ann Rheum Dis 2020
653
10

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
Serre-Yu Wong, Rebekah Dixon, Vicky Martinez Pazos, Sacha Gnjatic, Jean-Frederic Colombel, Ken Cadwell. Gastroenterology 2021
77
12

Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.
Abdulla Watad, Gabriele De Marco, Hussein Mahajna, Amit Druyan, Mailam Eltity, Nizar Hijazi, Amir Haddad, Muna Elias, Devy Zisman, Mohammad E Naffaa,[...]. Vaccines (Basel) 2021
156
10

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
Noa Dagan, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A Katz, Miguel A Hernán, Marc Lipsitch, Ben Reis, Ran D Balicer. N Engl J Med 2021
10

American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, Reuben J Arasaratnam, Lindsey R Baden, Anne R Bass, Cassandra Calabrese, Ellen M Gravallese, Rafael Harpaz, Rebecca E Sadun,[...]. Arthritis Rheumatol 2021
100
10

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.
Matthias B Moor, Franziska Suter-Riniker, Michael P Horn, Daniel Aeberli, Jennifer Amsler, Burkhard Möller, Linet M Njue, Cesare Medri, Anne Angelillo-Scherrer, Luca Borradori,[...]. Lancet Rheumatol 2021
103
10

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.
Ayelet Grupper, Liane Rabinowich, Doron Schwartz, Idit F Schwartz, Merav Ben-Yehoyada, Moshe Shashar, Eugene Katchman, Tami Halperin, Dan Turner, Yaacov Goykhman,[...]. Am J Transplant 2021
200
10

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Leticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, Duncan R McKenzie, Irene Del Molino Del Barrio, Thanussuyah Alaguthurai, Clara Domingo-Vila, Thomas S Hayday, Carl Graham, Jeffrey Seow,[...]. Lancet Oncol 2021
297
10

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
Lisa A Jackson, Evan J Anderson, Nadine G Rouphael, Paul C Roberts, Mamodikoe Makhene, Rhea N Coler, Michele P McCullough, James D Chappell, Mark R Denison, Laura J Stevens,[...]. N Engl J Med 2020
9

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan,[...]. Lancet 2021
706
9

Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients.
Hector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski, Fabian Halleck, Ulrike Weber, Franziska Szelinski, Bernd Jahrsdörfer, Hubert Schrezenmeier, Carolin Ludwig, Arne Sattler,[...]. Sci Immunol 2021
124
9

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.
Arne Sattler, Eva Schrezenmeier, Ulrike A Weber, Alexander Potekhin, Friederike Bachmann, Henriette Straub-Hohenbleicher, Klemens Budde, Elena Storz, Vanessa Proß, Yasmin Bergmann,[...]. J Clin Invest 2021
125
9

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Yanjun Zhang, Gang Zeng, Hongxing Pan, Changgui Li, Yaling Hu, Kai Chu, Weixiao Han, Zhen Chen, Rong Tang, Weidong Yin,[...]. Lancet Infect Dis 2021
650
8

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Jeffrey A Sparks, Zachary S Wallace, Andrea M Seet, Milena A Gianfrancesco, Zara Izadi, Kimme L Hyrich, Anja Strangfeld, Laure Gossec, Loreto Carmona, Elsa F Mateus,[...]. Ann Rheum Dis 2021
76
10

mRNA vaccines - a new era in vaccinology.
Norbert Pardi, Michael J Hogan, Frederick W Porter, Drew Weissman. Nat Rev Drug Discov 2018
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.